CRAVEN HOUSE CAPITAL PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2 USD | 0.00% |
|
0.00% | +33.33% |
| Feb. 28 | EARNINGS: Hutchmed revenue surges, Craven House's loss widens | AN |
| Feb. 28 | Craven House Capital Plc Reports Earnings Results for the Half Year Ended November 30, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Craven House Capital Plc is a United Kingdom-based investment company. The Companyâs investing policy is primarily to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets participating in the e-commerce sector. Its investment portfolio comprises Garimon Limited, Stormfjord Limited, BioVitos Medical Limited, Rosedog Limited, and Honeydog Limited. Garimon Limitedâs assets comprise ownership of the domain www.magazinos.com, a platform for digital magazine distribution. BioVitos Medical Limited has a license to market a patented heart drug, Succifer. Rosedog Limited is the owner of TV Zinos (www.tvzinos.com), a Website which offers a number of free-to-view television channels. The Companyâs investment manager is Desmond Holdings Ltd.
Calendar
2024-11-26
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +33.33% | 773K | |
| -6.04% | 113B | |
| -3.41% | 87.84B | |
| +20.96% | 64.04B | |
| +4.46% | 61.27B | |
| +11.34% | 43.34B | |
| +8.70% | 41.12B | |
| +17.64% | 34.17B | |
| +3.13% | 24.84B | |
| -4.09% | 22.4B |
- Stock Market
- Equities
- CRV Stock
- News Craven House Capital Plc
- Craven House Remains Largest Shareholder In Bio Vitas Following DBP Deal
